188 related articles for article (PubMed ID: 36518662)
1.
Zhang Y; Qin H; Bian J; Ma Z; Yi H
Front Pharmacol; 2022; 13():1045179. PubMed ID: 36518662
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of SLC2A family genes as prognostic biomarkers and therapeutic targets.
Liu Y; Li X; Yang J; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
Heliyon; 2024 Apr; 10(8):e29655. PubMed ID: 38655365
[TBL] [Abstract][Full Text] [Related]
3. SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma.
Luo L; Su J; Zheng Y; Huang F; Huang R; Luo H
J Immunol Res; 2021; 2021():9938397. PubMed ID: 34604392
[TBL] [Abstract][Full Text] [Related]
4. Multiple facilitated glucose transporters SLC2As are required for normal mouse preimplantation embryo development.
Arhin SK; Zhao J; Ji X; Shi C; Tang J; Gu Y; Xi H; Cheng J; Qu X; Shi H; Jin X; Lv J
Am J Transl Res; 2019; 11(6):3412-3425. PubMed ID: 31312354
[TBL] [Abstract][Full Text] [Related]
5.
Wang Y; Wen H; Sun D
Ann Transl Med; 2022 May; 10(9):519. PubMed ID: 35928739
[TBL] [Abstract][Full Text] [Related]
6. Expressions of glucose transporter genes are diversely attenuated and significantly associated with prostate cancer progression.
Huang H; Song S; Liu W; Ye S; Bao Y; Mirza M; Li B; Huang J; Zhu R; Lian H
Am J Clin Exp Urol; 2023; 11(6):578-593. PubMed ID: 38148933
[TBL] [Abstract][Full Text] [Related]
7. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas.
Chai YJ; Yi JW; Oh SW; Kim YA; Yi KH; Kim JH; Lee KE
Surgery; 2017 Jan; 161(1):188-194. PubMed ID: 27842912
[TBL] [Abstract][Full Text] [Related]
9. Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics.
Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Li R; Gao Y; Qiu B; Tan F; Xue Q; Gao S; He J
DNA Cell Biol; 2020 Apr; 39(4):631-644. PubMed ID: 32096653
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
Front Immunol; 2022; 13():950001. PubMed ID: 36091041
[TBL] [Abstract][Full Text] [Related]
11. AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma.
Feng Z; Zhang Y; He M; Han Y; Cai C; Liu S; Liu P; Chen Y; Shen H; Zeng S
Cancer Cell Int; 2022 Mar; 22(1):111. PubMed ID: 35248033
[TBL] [Abstract][Full Text] [Related]
12. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
[TBL] [Abstract][Full Text] [Related]
13. Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma.
Yang B; Ji LL; Xu HL; Li XP; Zhou HG; Xiao T; Li XH; Gao ZY; Li JZ; Zhang WD; Wang GS; Li MJ
J Inflamm Res; 2021; 14():2389-2401. PubMed ID: 34163207
[TBL] [Abstract][Full Text] [Related]
14. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
Chen A; Ding S; Shen X; Lin X
Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
16. Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration.
Peng Q; Hao LY; Guo YL; Zhang ZQ; Ji JM; Xue Y; Liu YW; Lu JL; Li CG; Shi XL
World J Clin Cases; 2022 May; 10(13):3989-4019. PubMed ID: 35665115
[TBL] [Abstract][Full Text] [Related]
17. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.
Liu TT; Li R; Huo C; Li JP; Yao J; Ji XL; Qu YQ
Front Cell Dev Biol; 2021; 9():682002. PubMed ID: 34409029
[TBL] [Abstract][Full Text] [Related]
18. Expression of glucose transporters SLC2A1, SLC2A8, and SLC2A12 in different chicken muscles during ontogenesis.
Coudert E; Praud C; Dupont J; Crochet S; Cailleau-Audouin E; Bordeau T; Godet E; Collin A; Berri C; Tesseraud S; Métayer-Coustard S
J Anim Sci; 2018 Mar; 96(2):498-509. PubMed ID: 29401234
[TBL] [Abstract][Full Text] [Related]
19. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
Liu F; Wu H
J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
[TBL] [Abstract][Full Text] [Related]
20. An
Han Y; Wong FC; Wang D; Kahlert C
Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
